Insider: Venker Eric President & Immunovant CEO - Roivant Sciences Ltd.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,647,546 | 0 | 1,647,546 |
| Value | $46,674,978.18 | $0.00 | $46,674,978.18 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/17/2026 | DDS | 200,000 | Direct | COM | $28.24 | $5,648,000.00 | 1,647,546 |
| 02/13/2026 | DDS | 200,000 | Direct | COM | $26.49 | $5,298,000.00 | 1,654,597 |
| 01/12/2026 | DDS | 200,000 | Direct | COM | $21.92 | $4,384,000.00 | 1,654,597 |
| 12/24/2025 | DDS | 75,000 | Direct | COM | $22.53 | $1,689,750.00 | 1,654,597 |
| 12/23/2025 | DDS | 200,000 | Direct | COM | $22.45 | $4,490,000.00 | 1,611,749 |
| 12/09/2025 | DDS | 200,000 | Direct | COM | $20.85 | $4,170,000.00 | 1,497,908 |
| 10/17/2025 | DDS | 118,418 | Direct | COM | $17.06 | $2,020,211.08 | 1,504,959 |
| 10/16/2025 | DDS | 318,282 | Direct | COM | $17.05 | $5,426,708.10 | 1,504,959 |
| 10/15/2025 | DDS | 414,683 | Direct | COM | $16.93 | $7,020,583.19 | 1,504,959 |
| 10/13/2025 | DDS | 20,727 | Direct | COM | $16.25 | $336,813.75 | 1,504,959 |
| 10/09/2025 | DDS | 104,940 | Direct | COM | $16.30 | $1,710,522.00 | 1,504,959 |
| 10/08/2025 | DDS | 138,602 | Direct | COM | $16.20 | $2,245,352.40 | 1,504,959 |
| 10/07/2025 | DDS | 355,161 | Direct | COM | $16.15 | $5,735,850.15 | 1,504,959 |
| 10/06/2025 | DDS | 171,396 | Direct | COM | $16.34 | $2,800,610.64 | 1,504,959 |
| 09/23/2025 | DDS | 611,000 | Direct | COM | $14.83 | $9,061,130.00 | 1,504,959 |
| 09/22/2025 | DDS | 100,000 | Direct | COM | $15.01 | $1,501,000.00 | 2,115,959 |
| 09/22/2025 | DDS | 316,182 | Direct | COM | $14.99 | $4,739,568.18 | 2,215,959 |
| 09/19/2025 | DDS | 683,818 | Direct | COM | $14.95 | $10,223,079.10 | 1,969,767 |
| 08/20/2025 | DDS | 100,000 | Direct | COM | $11.72 | $1,172,000.00 | 1,653,585 |
| 07/21/2025 | DDS | 100,000 | Direct | COM | $11.52 | $1,152,000.00 | 1,462,223 |
| 06/20/2025 | DDS | 100,000 | Direct | COM | $11.45 | $1,145,000.00 | 1,462,223 |
| 06/03/2025 | DDS | 566,278 | Direct | COM | $11.22 | $6,353,639.16 | 1,462,223 |
| 06/02/2025 | DDS | 433,722 | Direct | COM | $11.07 | $4,801,302.54 | 1,243,475 |
| 05/20/2025 | DDS | 100,000 | Direct | COM | $10.95 | $1,095,000.00 | 1,077,197 |
| 04/21/2025 | DDS | 100,000 | Direct | COM | $10.22 | $1,022,000.00 | 1,116,345 |
| 1 2 3 4 Next Last You are at page 1 of 4 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research